Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Sunlight  COVID-19 treatment studies for Sunlight  C19 studies: Sunlight  Sunlight   Select treatmentSelect treatmentTreatmentsTreatments
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta
Lactoferrin Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
COVID-19 and sunlight: Impact on SARS-CoV-2 transmissibility, morbidity, and mortality
Sharun et al., Annals of Medicine and Surgery, doi:10.1016/j.amsu.2021.102419 (Review)
Sharun et al., COVID-19 and sunlight: Impact on SARS-CoV-2 transmissibility, morbidity, and mortality, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2021.102419 (Review)
Jun 2021   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Review of evidence for the benefits of sunlight exposure for COVID-19.
Sharun et al., 30 Jun 2021, peer-reviewed, 3 authors.
Contact: sharunkhansk@gmail.com, kdhama@rediffmail.com.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperSunlightAll
Abstract: Annals of Medicine and Surgery 66 (2021) 102419 Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.elsevier.com/locate/amsu Perspective COVID-19 and sunlight: Impact on SARS-CoV-2 transmissibility, morbidity, and mortality A R T I C L E I N F O A B S T R A C T Keywords COVID-19 SARS-CoV-2 Therapeutics Photodynamic therapy Simulated sunlight Photo-biomodulation Coronavirus disease 2019 (COVID-19) has already affected millions of people worldwide. There are reports of SARS-CoV-2 transmission as a consequence of environmental contamination. The SARS-CoV-2 laden infective droplets can actively persist on the surface of different materials for several hours to days. Sunlight can affect the stability of SARS-CoV-2 in these aerosols and thereby have an impact on the decay rate of the virus. Solar ra­ diation might play an important role in inactivating SARS-CoV-2 that persists in different surfaces and the environment. Among the different climatological factors, ultraviolet radiation was found to have an important role in determining the spread of SARS-CoV-2. Although ultraviolet radiation C (UVC), UVB, UVA, visible light, and infrared radiation possess germicidal properties, human CoVs including the recently emerged SARS-CoV-2 are inherently sensitive to UVC. However, the successful decontamination using other wavebands requires higher dosages and longer administration times. Furthermore, studies have also identified association between COVID-19 fatalities and the latitude. The intensity of sunlight is highest near the equator, and therefore pop­ ulations in these regions with more regular exposure to sunlight are less susceptible to vitamin D deficiency. This article has analyzed the potential impact of sunlight in reducing SARS-CoV-2 transmissibility, morbidity, and mortality. It is evident that there exists an interesting link between sunlight exposure, latitude, and vitamin D status with COVID-19 incidence, fatality and recovery rates that requires further investigation. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported from the Huanan seafood market in Wuhan, Hubei prov­ ince, China [1]. It has now affected over 164 million people worldwide, with nearly 3.5 million deaths reported globally as of May 18, 2021. SARS-CoV-2 got rapidly spread across the world as a result of the effi­ cient human-to-human transmission. However, the air travel further facilitated the distribution of COVID-19 across international border at a faster rate [2]. SARS-CoV-2 is the sixth coronavirus that can infect human beings [1]. Among the previous coronaviruses (CoVs), SARS-CoV-2 exhibited close genomic similarity with SARS-CoV [3]. High efforts are being made continuously to develop effective vac­ cines, drugs and therapies to counter this pandemic disease that is posing high global threats and challenges to humanity [4–6]. Photody­ namic therapy, photo-biomodulation and light-based technologies have been reported to effectively inactivate SARS-CoV-2 and aid in the management and treatment of COVID-19 during this pandemic crisis [7–11]. The present study aims to analyze the available literature to evaluate the potential role of sunlight in reducing morbidity and mor­ tality associated with SARS-CoV-2 infection in humans. This article also presents an overview of the potential impact of sunlight in reducing SARS-CoV-2 transmissibility. The ability of infectious particles containing..
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit